Pharmacy Services M&A

A transaction-underwriting guide to specialty pharmacy M&A, including buyer demand, script volume, patient persistence, therapy and drug mix, PBM and payer access, limited-distribution drugs, accreditation, 340B relationships, DSCSA, hub services, revenue cycle, inventory, working capital, EBITDA quality, valuation, structure, integration, and seller proceeds.